Literature DB >> 1370384

Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor.

V C Broudy1, N Lin, K M Zsebo, N C Birkett, K A Smith, I D Bernstein, T Papayannopoulou.   

Abstract

Stem cell factor (SCF) stimulates the growth of burst-forming unit-erythroid (BFU-E) and colony-forming unit granulocyte-macrophage (CFU-GM) by binding to a specific cell surface receptor. The receptor for SCF is encoded by the protooncogene c-kit. After immunizing mice with the human erythroleukemia cell line OCIM1, we obtained a monoclonal antibody (MoAb) that recognizes the human c-kit receptor. This MoAb, designated SR-1, blocks binding of 125I-human SCF to the c-kit receptor, and neutralizes the biologic effects of SCF in hematopoietic colony assays. With few exceptions, c-kit expression was identified on all hematopoietic and lymphoid cell lines tested by indirect immunofluorescent analysis using SR-1 and by binding studies with 125I-SCF. SR-1 recognizes a small fraction of normal bone marrow mononuclear cells, and these cells have the morphologic appearance of blasts. Colony assays show that BFU-E and CFU-GM display the c-kit receptor. SR-1 does not cross-react with murine c-kit protein, indicating that the binding epitopes of the human and murine c-kit receptors are antigenically distinct. This MoAb may be useful to characterize the spectrum of cells that display the c-kit receptor and to further define the role of SCF in hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370384

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Chymase cleavage of stem cell factor yields a bioactive, soluble product.

Authors:  B J Longley; L Tyrrell; Y Ma; D A Williams; R Halaban; K Langley; H S Lu; N M Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.

Authors:  S M Geary; L K Ashman
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

5.  A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.

Authors:  Maria B Lebron; Laura Brennan; Christopher B Damoci; Marie C Prewett; Marguerita O'Mahony; Inga J Duignan; Kelly M Credille; James T DeLigio; Marina Starodubtseva; Michael Amatulli; Yiwei Zhang; Kaben D Schwartz; Douglas Burtrum; Paul Balderes; Kris Persaud; David Surguladze; Nick Loizos; Keren Paz; Helen Kotanides
Journal:  Cancer Biol Ther       Date:  2014-06-12       Impact factor: 4.742

6.  Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.

Authors:  Badreddin Edris; Stephen B Willingham; Kipp Weiskopf; Anne K Volkmer; Jens-Peter Volkmer; Thomas Mühlenberg; Kelli D Montgomery; Humberto Contreras-Trujillo; Agnieszka Czechowicz; Jonathan A Fletcher; Robert B West; Irving L Weissman; Matt van de Rijn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  Modeling promising nonmyeloablative conditioning regimens in nonhuman primates.

Authors:  Devikha Chandrasekaran; Betty Nakamoto; Korashon L Watts; Hans-Peter Kiem; Thalia Papayannopoulou
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

8.  The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

Authors:  W E Carson; S Haldar; R A Baiocchi; C M Croce; M A Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Authors:  L S Rusten; E B Smeland; F W Jacobsen; E Lien; W Lesslauer; H Loetscher; C M Dubois; S E Jacobsen
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  c-KIT expression enhances the leukemogenic potential of 32D cells.

Authors:  Q Hu; M Trevisan; Y Xu; W Dong; S A Berger; S D Lyman; M D Minden
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.